Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
about
Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.
P2860
Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
description
article
@en
im Oktober 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2014
@uk
name
Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
@en
Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
@nl
type
label
Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
@en
Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
@nl
prefLabel
Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
@en
Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
@nl
P2860
P356
P1433
P1476
Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
@en
P2093
Helena Cortez-Pinto
Mariana V Machado
P2860
P304
P356
10.1111/LIV.12578
P407
P577
2014-10-01T00:00:00Z